Lite Strategy, Inc. (ticker: LITS) is an NASDAQ-listed pharmaceutical preparations company. DredgeCap's structured extraction of LITS's SEC filings surfaces 3 active risk signals, including 1 auditor-change signal, 1 delisting/deregistration signal, and 1 late-filing signal. LITS reported $0 in revenue and -$58.13M for the period ending 2025-06-30, with operating cash flow of -$7.96M. Cash and equivalents stood at $7.54M (down 63.1% year-over-year). Total assets of $57.79M exceed total liabilities of $952K. Each signal on this page is sourced verbatim from the underlying SEC filing. Use the tabs above to drill into auditor history, going-concern citations, dilution mechanics, cash runway, and the full risk-flag inventory.
LITS SEC Filings
Full cached SEC EDGAR filing history for LITS, grouped by form type and sorted newest-first within each group. 0 filings across 0 form types.
Filings sourced verbatim from SEC EDGAR submissions metadata. “Structured” links route to DredgeCap's per-filing renderer (XBRL-backed financials + cited highlights) when available; the EDGAR link always points to the canonical accession index on sec.gov.